FiercePharmaAsia—NextCODE’s $240M financing, Celltrion’s Inflectra plant, Biocon’s insulin plant
admin 15th September 2017 Uncategorised 0WuXi NextCODE has raised $240 million in a series B to build its genomics business, FDA slapped Pfizer’s partner Celltrion with a 12-observation Form 483, Biocon’s $275 million insulin plant in Malaysia opened shop and more.
More: FiercePharmaAsia—NextCODE’s 0M financing, Celltrion’s Inflectra plant, Biocon’s insulin plant
Source: fierce